The app, called COPD Navigator, was developed by BioTime subsidiary LifeMap Sciences’ mobile health spinoff company, LifeMap Solutions, in collaboration with researchers from the Icahn School of Medicine at Mount Sinai. The app displays data visually to help patients understand patterns in their behavior and shares the information with their physicians. It also sends alerts about local air quality and water to patients to help them avoid environmental risks, according to MedCity News.
The pilot program aims to gather feedback from patients and respiratory specialists to evaluate how successful the technology is in a clinical setting as well as to gauge how successful it is at encouraging self-management of COPD, according to the report.
LifeMap also produces a Bluetooth-enabled inhaler and a clinician dashboard for care providers to manage COPD symptoms. COPD Navigator supports Apple’s HealthKit technology and accepts data from any HealthKit-enabled, Bluetooth-connected inhaler. For the pilot at Mount Sinai, LifeMap provided a smart device of its own design that connects to the app to allow closer tracking, according to the report.
